Coric, V., et al. (2012) Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease. Archives of Neurology, 69, 1430-1440. http://dx.doi.org/10.1001/archneurol.2012.2194
has been cited by the following article:
Related Articles: